Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20171212037850N1
IRCT20171212037850N1CompletedPhase 3

A comparative study on the efficacy of levetiracetam and amitriptyline in childhood migraine; An open-label randomized controlled trial

Esfahan University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
60
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
5 years to 15 years (—)
Sex
All

Inclusion Criteria

  • •All of children with migraine headache with or without aura, at least two attack per week or four attack per month, so that the attacks cause them to consume the analgesics or interfere with everyday activities

Exclusion Criteria

  • •Complicated migraine
  • •Not having the ability to record data related to the number, duration, and severity of headaches
  • •Use of other prophylactic drugs other than Levetiracetam and Amitriptyline
  • •Severe psychiatric problems like depression and ADHD
  • •Hypersensitivity to tricyclic anti depressants drugs
  • •Taking analgesic more than 4 times a week for migraine headache

Investigators

Similar Trials

Recruiting
Phase 3
The Comparison of efficacy of Levetiracetam and Carbamazepine in the treatment of Rolandic seizures in childre
IRCT20190208042654N3Esfahan University of Medical Sciences94
Not yet recruiting
Phase 4
Comparison of the therapeutic effects of levetiracetam and sodium valproate on the containment of migraine headaches52 patients suffering from migraine were evenly assigned to two groups of A (receivers of sodium valproate) and B (receivers of levetiracetam). Patients of both groups visited the hospital in three moLevetiracetamsodium valproatemigraine headaches
TCTR20161213001Azad Islamic University52
Completed
Phase 2
evetiractem for the prophylactic treatment of pediatric migrainemigraine headache.migraine without aura or clasic migraine
IRCT2017021632603N1Vice chancellor for research, Tehran university of medical sciense68
Recruiting
Phase 2
A randomized phase IIb study comparing levetiracetam alone with lacosamide add-on for reduction of epileptic seizure after brain tumor surgeryBrain tumors
JPRN-UMIN000031896Department of Neurosurgery, University of Tsukuba235
Recruiting
Phase 3
Comparison of Effectiveness of Levetiracetam With Phenytoin in Postcraniotomy Seizure in the Patients with Supratentorial Brain Tumors :RCT-Single BlindComparison of Effectiveness of Levetiracetam With Phenytoin in Postcraniotomy Seizure in the Patients with Supratentorial Brain Tumors.
IRCT20150419021837N1Tehran University of Medical Sciences80